The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Big Ten Cancer Research Consortium phase II trial of pembrolizumab with carboplatin and paclitaxel for advanced or recurrent endometrial cancer.
 
Mario Javier Pineda
Research Funding - Merck Sharp & Dohme (Inst)
 
Jeanne Schilder
No Relationships to Disclose
 
Emily K. Hill
No Relationships to Disclose
 
Deanna Gek Koon Teoh
Research Funding - KCI; Tesaro
 
Emma Longley Barber
Research Funding - Lilly (Inst)
 
Sharon E. Robertson
No Relationships to Disclose
 
Anna Everett Strohl
No Relationships to Disclose
 
Jiahui Xu
No Relationships to Disclose
 
Masha Kocherginsky
Patents, Royalties, Other Intellectual Property - Royalties - co-inventor on Patent 9149485, "Methods and compositions related to glucocorticoid receptor antagonists and breast cancer".
 
Daniela Matei
Honoraria - AstraZeneca; Genentech/Roche; Radius Health; Tesaro
Consulting or Advisory Role - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Roche/Genentech
Research Funding - Merck; Merck
Travel, Accommodations, Expenses - AstraZeneca; Genentech/Roche; Radius Health